Literature DB >> 31116925

Active Surveillance for Low-Risk Prostate Cancer in Black Patients.

Santino Butler1, Vinayak Muralidhar1, Janice Chavez1, Zoe Fullerton1, Aman Mahal2, Michelle Nezolosky1, Marie Vastola1, Shuang G Zhao3, Anthony V D'Amico1, Robert T Dess3, Felix Y Feng4, Martin T King1, Kent W Mouw1, Daniel E Spratt3, Quoc-Dien Trinh1, Paul L Nguyen1, Timothy R Rebbeck1, Brandon A Mahal5.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31116925     DOI： 10.1056/NEJMc1900333

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  17 in total

1.  Prostate Cancer Disparities in Risk Group at Presentation and Access to Treatment for Asian Americans, Native Hawaiians, and Pacific Islanders: A Study With Disaggregated Ethnic Groups.

Authors:  Bhav Jain; Kenrick Ng; Patricia Mae G Santos; Kekoa Taparra; Vinayak Muralidhar; Brandon A Mahal; Neha Vapiwala; Quoc-Dien Trinh; Paul L Nguyen; Edward Christopher Dee
Journal:  JCO Oncol Pract       Date:  2021-10-28

2.  Trends in treatments for prostate cancer in the United States, 2010-2015.

Authors:  Jianwei Wang; Harry Hua-Xiang Xia; Yuanyuan Zhang; Lanjing Zhang
Journal:  Am J Cancer Res       Date:  2021-05-20       Impact factor: 6.166

3.  Life expectancy estimates for patients diagnosed with prostate cancer in the Veterans Health Administration.

Authors:  Ericka M Sohlberg; I-Chun Thomas; Jaden Yang; Kristopher Kapphahn; Timothy J Daskivich; Ted A Skolarus; Jeremy B Shelton; Danil V Makarov; Jonathan Bergman; Christine Ko Bang; Mary K Goldstein; Todd H Wagner; James D Brooks; Manisha Desai; John T Leppert
Journal:  Urol Oncol       Date:  2020-07-13       Impact factor: 3.498

4.  Association Between African American Race and Clinical Outcomes in Men Treated for Low-Risk Prostate Cancer With Active Surveillance.

Authors:  Rishi Deka; P Travis Courtney; J Kellogg Parsons; Tyler J Nelson; Vinit Nalawade; Elaine Luterstein; Daniel R Cherry; Daniel R Simpson; Arno J Mundt; James D Murphy; Anthony V D'Amico; Christopher J Kane; Maria Elena Martinez; Brent S Rose
Journal:  JAMA       Date:  2020-11-03       Impact factor: 56.272

5.  A 17-Gene Panel Genomic Prostate Score Has Similar Predictive Accuracy for Adverse Pathology at Radical Prostatectomy in African American and European American Men.

Authors:  Adam B Murphy; Samuel Carbunaru; Oluwarotimi S Nettey; Chase Gornbein; Michael A Dixon; Virgilia Macias; Roohollah Sharifi; Rick A Kittles; Ximing Yang; Andre Kajdacsy-Balla; Peter Gann
Journal:  Urology       Date:  2020-04-08       Impact factor: 2.649

Review 6.  Progression on active surveillance for prostate cancer in Black men: a systematic review and meta-analysis.

Authors:  Hari T Vigneswaran; Luke Mittelstaedt; Alessio Crippa; Martin Eklund; Adriana Vidal; Stephen J Freedland; Michael R Abern
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-07-08       Impact factor: 5.554

7.  Factors Associated with Time to Conversion from Active Surveillance to Treatment for Prostate Cancer in a Multi-Institutional Cohort.

Authors:  Lauren Folgosa Cooley; Adaeze A Emeka; Travis J Meyers; Phillip R Cooper; Daniel W Lin; Antonio Finelli; James A Eastham; Christopher J Logothetis; Leonard S Marks; Danny Vesprini; S Larry Goldenberg; Celestia S Higano; Christian P Pavlovich; June M Chan; Todd M Morgan; Eric A Klein; Daniel A Barocas; Stacy Loeb; Brian T Helfand; Denise M Scholtens; John S Witte; William J Catalona
Journal:  J Urol       Date:  2021-09-10       Impact factor: 7.600

8.  The Impact of Intensifying Prostate Cancer Screening in Black Men: A Model-Based Analysis.

Authors:  Yaw A Nyame; Roman Gulati; Eveline A M Heijnsdijk; Alex Tsodikov; Angela B Mariotto; John L Gore; Ruth Etzioni
Journal:  J Natl Cancer Inst       Date:  2021-10-01       Impact factor: 11.816

9.  African American Race is Not Associated with Risk of Reclassification during Active Surveillance: Results from the Canary Prostate Cancer Active Surveillance Study.

Authors:  Jeannette M Schenk; Lisa F Newcomb; Yingye Zheng; Anna V Faino; Kehao Zhu; Yaw A Nyame; James D Brooks; Peter R Carroll; Matthew R Cooperberg; Atreya Dash; Christopher P Filson; Martin E Gleave; Michael Liss; Francis M Martin; Todd M Morgan; Peter S Nelson; Ian M Thompson; Andrew A Wagner; Daniel W Lin
Journal:  J Urol       Date:  2019-10-25       Impact factor: 7.450

10.  Trends and practices for managing low-risk prostate cancer: a SEER-Medicare study.

Authors:  Richard M Hoffman; Sarah L Mott; Bradley D McDowell; Sonia T Anand; Kenneth G Nepple
Journal:  Prostate Cancer Prostatic Dis       Date:  2021-06-09       Impact factor: 5.455
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.